SOURCE: Traders Insight

November 13, 2012 09:00 ET

Direction Change Ahead, What to Expect - Research & Analysis on Gilead Sciences, Inc. and Idenix Pharmaceuticals, Inc.

JAKARTA, INDONESIA--(Marketwire - Nov 13, 2012) - Moments ago, TradersInsight.net introduced new coverage of Gilead Sciences, Inc. (NASDAQ: GILD) and Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX). Full outlook, analysis and consensus opinion is available to readers via the links below.

www.TradersInsight.net/r/cnbc/e665_GILD
www.TradersInsight.net/r/cnbc/ad8f_IDIX

The consistent delivery of accurate analyses relies solely on two factors, namely: market awareness and industry insight. Recent market drivers include grim European forecasts with Germany's growth prospects signaling potential trouble ahead, headlines of "fiscal cliff" concerns with potential friction between Republicans and Democrats regarding upcoming expiration of tax cuts and recent effects of Hurricane Sandy still affecting major areas. When it comes to discovering the right edge at the right time, all these factors play into effect. For a deeper understanding of the mechanics behind these events and how it can affect your portfolio, please refer to our email newsletter delivered to your inbox.

Traders Insight is releasing new coverage on Gilead Sciences, Inc. for its current position within the health care sector. Gilead Sciences, Inc. (Gilead) is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Gilead's primary areas of focus include human immunodeficiency virus (HIV)/AIDS, liver diseases, such as hepatitis B and C and cardiovascular/metabolic and respiratory conditions. A copy of this report featuring Gilead Sciences, Inc. (NASDAQ: GILD) is available at: www.TradersInsight.net/r/cnbc/e665_GILD.

Traders Insight has released research on Idenix Pharmaceuticals, Inc. for its changing role within the consumer durables sector. Idenix Pharmaceuticals, Inc. (Idenix) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and Europe. To access the full research report on Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) we welcome investors to visit: www.TradersInsight.net/r/cnbc/ad8f_IDIX.

About Traders Insight
Find direction and insight with TradersInsight.net. Our model of enabling open collaboration between members is breaking new ground into the investment community. By tapping into the resources of the community, we are crowd-sourcing our reach. As a result - we have been able to identify some of the greatest moving companies on the market today. The evidence is in the results, join today and experience what you've been missing.

Contact Information